Simulations Plus Inc.

-0.32 (-0.60%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.07B
Current PE98.99
Forward PE 98.56
2yr Forward PE 83.16
See more stats
Estimates Current Quarter
Revenue$14.74 Million
Adjusted EPS$0.18
See more estimates
10-Day MA$54.00
50-Day MA$56.48
200-Day MA$65.85
See more pivots

Simulations Plus Inc. Stock, NASDAQ:SLP

42505 10th Street West, Lancaster, California 93534-7059
Phone: +1.661.723.7723
Number of Employees: 137


Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. It operates through the following segments: Simulations Plus, Inc., Cognigen Corporation, DILIsym, and Lixoft. It designs and develops pharmaceutical simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education of pharmacy and medical students. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Lancaster, CA.